XCUR — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

14.15

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

1.27

Target Price

10.33

Analyst Recom

Performance Q

-60.9

Upside

-1,628.2%

Beta

3.62

Ticker: XCUR

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	XCUR	1.63	N/A	N/A	0
2026-07-14	XCUR	1.705	N/A	N/A	0
2026-07-15	XCUR	1.63	N/A	N/A	0
2026-07-16	XCUR	1.6	N/A	N/A	0
2026-07-17	XCUR	1.72	N/A	N/A	0
2026-07-20	XCUR	1.89	N/A	N/A	0
2026-07-21	XCUR	1.9	N/A	N/A	0
2026-07-22	XCUR	1.71	N/A	N/A	0
2026-07-23	XCUR	1.71	N/A	N/A	0
2026-07-24	XCUR	1.73	N/A	N/A	0
2026-07-27	XCUR	1.74	N/A	N/A	0
2026-07-28	XCUR	1.71	N/A	N/A	0
2026-07-29	XCUR	1.73	N/A	N/A	0
2026-07-30	XCUR	1.61	N/A	N/A	0
2026-07-31	XCUR	1.63	N/A	N/A	0
2026-08-03	XCUR	1.51	N/A	N/A	0
2026-08-04	XCUR	1.55	N/A	N/A	0
2026-08-05	XCUR	1.57	N/A	N/A	0
2026-08-06	XCUR	1.33	N/A	N/A	0
2026-08-07	XCUR	1.305	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	XCUR	1.65	-	-	-
2026-07-14	XCUR	1.66	-	-	-
2026-07-15	XCUR	1.62	-	-	-
2026-07-16	XCUR	1.59	-	-	-
2026-07-17	XCUR	1.65	-	-	-
2026-07-20	XCUR	1.89	-	-	-
2026-07-21	XCUR	1.90	-	-	-
2026-07-22	XCUR	1.71	-	-	-
2026-07-23	XCUR	1.71	-	-	-
2026-07-24	XCUR	1.74	-	-	-
2026-07-27	XCUR	1.73	-	-	-
2026-07-28	XCUR	1.72	-	-	-
2026-07-29	XCUR	1.74	-	-	-
2026-07-30	XCUR	1.60	-	-	-
2026-07-31	XCUR	1.64	-	-	-
2026-08-03	XCUR	1.59	-	-	-
2026-08-04	XCUR	1.59	-	-	-
2026-08-05	XCUR	1.51	-	-	-
2026-08-06	XCUR	1.31	-	-	-
2026-08-07	XCUR	1.27	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	XCUR	-31.43	-0.01	0.16
2026-07-14	XCUR	-31.43	-0.01	0.16
2026-07-15	XCUR	-31.41	-0.01	0.16
2026-07-16	XCUR	-31.43	-0.01	0.16
2026-07-17	XCUR	-31.41	-0.01	0.16
2026-07-20	XCUR	-31.42	-0.01	0.16
2026-07-21	XCUR	-10.65	-0.01	0.16
2026-07-22	XCUR	0.00	-0.01	0.16
2026-07-23	XCUR	0.00	-0.01	0.16
2026-07-24	XCUR	0.00	-0.01	0.16
2026-07-27	XCUR	0.00	-0.02	14.15
2026-07-28	XCUR	0.00	-0.02	14.15
2026-07-29	XCUR	0.00	-0.02	14.15
2026-07-30	XCUR	0.00	-0.02	14.15
2026-07-31	XCUR	0.00	-0.02	14.15
2026-08-03	XCUR	0.00	-0.02	14.15
2026-08-04	XCUR	0.00	-0.02	14.15
2026-08-05	XCUR	0.00	-0.02	14.15
2026-08-06	XCUR	0.00	-0.02	14.15
2026-08-07	XCUR	0.00	-0.02	14.15
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-0.02

Beta

3.62

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.4

Max Drawdown 5-Year %

-99.4

Target Price

10.33

P/E

Forward P/E

PEG

P/S

P/B

3.98

P/Free Cash Flow

EPS

-1.54

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.1

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ XCUR Healthcare

$1.31

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

11/25

Volume

11/15

Valuation

12/20

TP/AR

2/10

Options

0/10

RSI

27.9

Range 1M

4.4%

Sup Dist

2.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

4/30

Estimates

0/20

Inst/Vol

0/15

Options

0/10

EPS Yr

EPS NY

52W%

0.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +688.5% upside

Quality

2/30

Valuation

16/30

Growth

0/25

Stability

4/10

LT Trend

4/5

Upside

+688.5%

Quality

XCUR — P/E HistoricalBiotechnology

Exicure, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 2

Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.

XCUR

Latest News

—

Caricamento notizie per XCUR…

stock quote shares XCUR – Exicure Inc. Stock Price stock today

news today XCUR – Exicure Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch XCUR – Exicure Inc. yahoo finance google finance

stock history XCUR – Exicure Inc. invest stock market

stock prices XCUR premarket after hours

ticker XCUR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: XCUR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y